UnknownNCT04916834

Impact of Severe Acute Respiratory Syndrome (SARS-CoV-2/COVID-19) Related Pneumonia on Lung Function and Structure.

Studying Severe acute respiratory syndrome

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
National Institute for Tuberculosis and Lung Diseases, Poland
Principal Investigator
Piotr W Boros, MD, PhD
National TB & Lung Diseases Research Institute
Enrollment
100 target
Eligibility
18-100 years · All sexes
Timeline
20202024

Study locations (1)

Collaborators

Medical University of Warsaw

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT04916834 on ClinicalTrials.gov

Other trials for Severe acute respiratory syndrome

Additional recruiting or active studies for the same condition.

See all trials for Severe acute respiratory syndrome

← Back to all trials